Galderma expands its footprint in Texas

FORT WORTH, Texas -- Galderma Laboratories is expanding its North American headquarters by adding a 100,000-square-foot Research and Development center to the current 170,000-square-foot campus in Fort Worth, Texas.

The company says the $22 million R&D, training and office building will also add up to 350 new positions to the company over the next few years, increasing home office employees to more than 600. 

"This expansion shows Galderma's commitment to both skin health innovation and the Fort Worth community," said Miles Harrison, General Manager and President of Galderma North America. "It's a game-changer in that it will allow us to double the number of staff at our North American headquarters, increase our talent and concentrate on our one and only focus: providing for skin health needs at every stage of life."

Under the umbrella of Nestlé Skin Health, Galderma says it has lately been experiencing a tremendous amount of growth following the launch of nine products in the past 20 months, including Cetaphil Men and Baby lines; prescription Soolantra (ivermectin) Cream, 1%; Epiduo Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5%; and the aesthetic treatments, Restylane Silk and Restylane Lyft.